Skip to main content

Psychiatry, Mental Health and Addictions

The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 13 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of:

  • Neurodevelopmental Disorders (especially Attention-Deficit / Hyperactivity Disorder, Autism and Fetal Alcohol Syndrome).
  • Personality Disorders (especially Borderline Personality Disorder).
  • Addictive behaviours (especially Dual Pathology and Smoking).
  • Transcultural Psychiatry.
  • Interconsultation and Liaison Psychiatry.
  • Resistant Major Depressive Disorder.
  • Perinatal psychiatry.
  • Child sexual abuse and maltreatment.

At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. At national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network) together with other leading groups, conducting research of excellence.

Team

Victoria López Craver

Victoria López Craver

Psychiatry, Mental Health and Addictions
Read more
Zaira Nieto Fernández

Zaira Nieto Fernández

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Victoria López Craver

Victoria López Craver

Psychiatry, Mental Health and Addictions
Read more
Zaira Nieto Fernández

Zaira Nieto Fernández

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Blog

News

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.